Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

The cynic in me thinks they are only going for Semaglutide because the patent expires in several places in 2026, tirzepatide has another ten years.


The patent on the manufacturing process, not the peptide itself.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: